
Full profile: /officials/P000595
Source: Congress.gov · FEC
Members who have signed on to support this bill since introduction. Source: Congress.gov.
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
2025-12-11
Source: Congress.gov
Currently in
Previously
This bill would restrict certain Chinese companies and entities from owning or investing in U.S. biotechnology and pharmaceutical businesses, aiming to protect American medical research and drug development from foreign control. It affects biotech startups, pharmaceutical companies, and research institutions that might otherwise receive funding or investment from Chinese sources. The measure reflects concerns about keeping sensitive health and medical technology development within U.S. hands.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Bills by the same sponsor or covering overlapping subjects.